RICHTER TRANSFORMATION LYMPHOMA

Clinical trials for RICHTER TRANSFORMATION LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RICHTER TRANSFORMATION LYMPHOMA trials appear

Sign up with your email to follow new studies for RICHTER TRANSFORMATION LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for patients who have run out of options for blood cancers

Disease control Ongoing

This study is testing a new drug called zilovertamab vedotin (MK-2140) for people with several types of advanced B-cell blood cancers that have come back or stopped responding to other treatments. The main goals are to see if the drug is safe and if it can shrink or eliminate the…

Matched conditions: RICHTER TRANSFORMATION LYMPHOMA

Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

RICHTER TRANSFORMATION LYMPHOMA

Get alerted when new RICHTER TRANSFORMATION LYMPHOMA trials appear

New hope for patients who have run out of options for blood cancers